Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19297572 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Recombinant CMV gB Vaccine in Postpartum Women
Condition: Cytomegalovirus Infections
Interventions: Biological: CMV gB vaccine;   Drug: MF59 adjuvant;   Drug: Placebo

Indicates status has not been verified in more than two years